{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:34:34Z","timestamp":1787776474583,"version":"build-2784847793"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"DOI":"10.1007\/s00270-026-04589-y","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:15:46Z","timestamp":1787775346000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Outcomes in Chronic Limb-Threatening Ischemia\u00a0Patients Undergoing Femoropopliteal Endovascular\u00a0Treatment Using\u00a0IN.PACT\u00a0versus Ranger: Results of the PEPPERMINT Study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4919-6625","authenticated-orcid":false,"given":"Satoru","family":"Nagatomi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuyoshi","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taira","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terutoshi","family":"Yamaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanobu","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Shingaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyosuke","family":"Hosokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Furuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsunehiro","family":"Shintani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Sekimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoichi","family":"Kyuragi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Watada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Morisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Mitsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Banno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Obara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Ichihashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the PEPPERMINT Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"issue":"5","key":"4589_CR1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","volume":"131","author":"G Tepe","year":"2015","unstructured":"Tepe G, Laird J, Schneider P, Brodmann M, Krishnan P, Micari A, et al. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation. 2015;131(5):495\u2013502. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.011004.","journal-title":"Circulation"},{"issue":"2","key":"4589_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJMoa1406235","volume":"373","author":"K Rosenfield","year":"2015","unstructured":"Rosenfield K, Jaff MR, White CJ, Rocha-Singh K, Mena-Hurtado C, Metzger DC, et al. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med. 2015;373(2):145\u201353. https:\/\/doi.org\/10.1056\/NEJMoa1406235.","journal-title":"N Engl J Med"},{"issue":"10","key":"4589_CR3","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jcin.2021.03.021","volume":"14","author":"R Sachar","year":"2021","unstructured":"Sachar R, Soga Y, Ansari MM, Kozuki A, Lopez L, Brodmann M, et al. 1-year results from the RANGER II SFA randomized trial of the Ranger drug-coated balloon. JACC Cardiovasc Interv. 2021;14(10):1123\u201333. https:\/\/doi.org\/10.1016\/j.jcin.2021.03.021.","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"4589_CR4","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.jvs.2019.01.080","volume":"70","author":"C Caradu","year":"2019","unstructured":"Caradu C, Lakhlifi E, Colacchio EC, Midy D, B\u00e9rard X, Poirier M, et al. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease. J Vasc Surg. 2019;70(3):981\u201395. https:\/\/doi.org\/10.1016\/j.jvs.2019.01.080.","journal-title":"J Vasc Surg"},{"issue":"2","key":"4589_CR5","doi-asserted-by":"publisher","first-page":"E129","DOI":"10.1002\/ccd.28572","volume":"96","author":"Y Xi","year":"2020","unstructured":"Xi Y, Chen J, Bi Y, Xie S, Liao T, Zhang Y, et al. Long-term clinical safety and efficacy of drug-coated balloon in the treatment of in-stent restenosis: a meta-analysis and systematic review. Catheter Cardiovasc Interv. 2020;96(2):E129\u201341. https:\/\/doi.org\/10.1002\/ccd.28572.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5","key":"4589_CR6","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jcin.2024.10.052","volume":"18","author":"SJ Lee","year":"2025","unstructured":"Lee SJ, Kim TH, Lee JH, Ahn CM, Lee SH, Lee YJ, et al. Intravascular ultrasound-guided vs angiography-guided drug-coated balloon angioplasty in patients with complex femoropopliteal artery disease. JACC Cardiovasc Interv. 2025;18(5):558\u201369. https:\/\/doi.org\/10.1016\/j.jcin.2024.10.052.","journal-title":"JACC Cardiovasc Interv"},{"issue":"7","key":"4589_CR7","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.jcin.2015.12.267","volume":"9","author":"A Schmidt","year":"2016","unstructured":"Schmidt A, Piorkowski M, G\u00f6rner H, Steiner S, Bausback Y, Scheinert S, et al. Drug-coated balloons for complex femoropopliteal lesions: 2-year results of a real-world registry. JACC Cardiovasc Interv. 2016;9(7):715\u201324. https:\/\/doi.org\/10.1016\/j.jcin.2015.12.267.","journal-title":"JACC Cardiovasc Interv"},{"key":"4589_CR8","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jacc.2018.11.039","volume":"73","author":"Y Bausback","year":"2019","unstructured":"Bausback Y, Wittig T, Schmidt A, Zeller T, Bosiers M, Peeters P, et al. Drug-eluting stent versus drug-coated balloon revascularization in patients with femoropopliteal arterial disease. J Am Coll Cardiol. 2019;73:667\u201379. https:\/\/doi.org\/10.1016\/j.jacc.2018.11.039.","journal-title":"J Am Coll Cardiol"},{"key":"4589_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jacc.2019.04.057","volume":"74","author":"F Liistro","year":"2019","unstructured":"Liistro F, Angioli P, Porto I, Ducci K, Falsini G, Ventoruzzo G, et al. Drug-eluting balloon versus drug-eluting stent for complex femoropopliteal arterial lesions: the DRASTICO study. J Am Coll Cardiol. 2019;74:205\u201315. https:\/\/doi.org\/10.1016\/j.jacc.2019.04.057.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"4589_CR10","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1177\/15266028241271725","volume":"33","author":"T Nakama","year":"2026","unstructured":"Nakama T, Takahara M, Iwata Y, Suzuki K, Tobita K, Hayakawa N, et al. One-year outcomes of drug-eluting stent versus drug-coated balloon for femoropopliteal artery lesions: BEASTARS study results. J Endovasc Ther. 2026;33(2):669\u201381. https:\/\/doi.org\/10.1177\/15266028241271725.","journal-title":"J Endovasc Ther"},{"issue":"6","key":"4589_CR11","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/j.jvs.2023.01.207","volume":"77","author":"S Nagatomi","year":"2023","unstructured":"Nagatomi S, Takahara M, Nakai T, Fujimura N, Yu A, Matsuda D, et al. Comparing the impact of the loss of patency between treatment with drug-coated balloon angioplasty and drug-eluting stent placement. J Vasc Surg. 2023;77(6):1751\u20139. https:\/\/doi.org\/10.1016\/j.jvs.2023.01.207.","journal-title":"J Vasc Surg"},{"key":"4589_CR12","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.ejvs.2018.11.019","volume":"57","author":"A Boitet","year":"2019","unstructured":"Boitet A, Grassin-Delyle S, Louedec L, et al. An experimental study of paclitaxel embolization during drug coated balloon angioplasty. Eur J Vasc Endovasc Surg. 2019;57:578\u201386. https:\/\/doi.org\/10.1016\/j.ejvs.2018.11.019.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"4589_CR13","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ejpb.2015.08.010","volume":"96","author":"W Kempin","year":"2015","unstructured":"Kempin W, Kaule S, Reske T, et al. In vitro evaluation of paclitaxel coatings for delivery via drug-coated balloons. Eur J Pharm Biopharm. 2015;96:322\u20138. https:\/\/doi.org\/10.1016\/j.ejpb.2015.08.010.","journal-title":"Eur J Pharm Biopharm"},{"issue":"20","key":"4589_CR14","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1016\/j.jcin.2022.08.004","volume":"15","author":"S Steiner","year":"2022","unstructured":"Steiner S, Schmidt A, Zeller T, Tepe G, Thieme M, Maiwald L, et al. Low-dose vs high-dose paclitaxel-coated balloons for femoropopliteal lesions: 2-year results from the COMPARE trial. JACC Cardiovasc Interv. 2022;15(20):2093\u2013102. https:\/\/doi.org\/10.1016\/j.jcin.2022.08.004.","journal-title":"JACC Cardiovasc Interv"},{"issue":"21","key":"4589_CR15","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1016\/j.jcin.2023.08.022","volume":"16","author":"T Nakama","year":"2023","unstructured":"Nakama T, Takahara M, Iwata Y, Suzuki K, Tobita K, Hayakawa N, et al. Low-dose vs high-dose drug-coated balloon for symptomatic femoropopliteal artery disease: the PROSPECT MONSTER study outcomes. JACC Cardiovasc Interv. 2023;16(21):2655\u201365. https:\/\/doi.org\/10.1016\/j.jcin.2023.08.022.","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"4589_CR16","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1002\/ccd.31485","volume":"105","author":"N Yoshioka","year":"2025","unstructured":"Yoshioka N, Tokuda T, Tanaka A, Kojima S, Yamaguchi K, Yanagiuchi T, et al. Comparing the clinical performance of high-dose and low-dose drug-coated balloons for long femoropopliteal artery disease: results of the SATELLITE study. Catheter Cardiovasc Interv. 2025;105(6):1453\u201361. https:\/\/doi.org\/10.1002\/ccd.31485.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5","key":"4589_CR17","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1253\/circj.CJ-24-0813","volume":"89","author":"K Ogata","year":"2025","unstructured":"Ogata K, Nishihira K, Komiya K, Baba K, Honda Y, Yamamoto K, et al. Clinical comparison of high- and low-dose drug-coated balloons for de novo chronic total occlusive femoropopliteal lesions. Circ J. 2025;89(5):566\u201373. https:\/\/doi.org\/10.1253\/circj.CJ-24-0813.","journal-title":"Circ J"},{"issue":"1","key":"4589_CR18","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jvs.2025.02.010","volume":"82","author":"T Kobayashi","year":"2025","unstructured":"Kobayashi T, Takahara M, Fujimura N, Yamaoka T, Matsuda D, Okazaki T, et al. Clinical outcomes in patients with chronic limb-threatening ischemia after femoropopliteal intervention with a drug-coated balloon or stenting. J Vasc Surg. 2025;82(1):164\u201372. https:\/\/doi.org\/10.1016\/j.jvs.2025.02.010.","journal-title":"J Vasc Surg"},{"issue":"1S","key":"4589_CR19","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ejvs.2019.05.006","volume":"58","author":"MS Conte","year":"2019","unstructured":"Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. Eur J Vasc Endovasc Surg. 2019;58(1S):S1-S109.e33. https:\/\/doi.org\/10.1016\/j.ejvs.2019.05.006.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"1","key":"4589_CR20","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jvs.2013.08.003","volume":"59","author":"JL Mills","year":"2014","unstructured":"Mills JL, Conte MS, Armstrong DG, et al. The Society for Vascular Surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg. 2014;59(1):220\u201334. https:\/\/doi.org\/10.1016\/j.jvs.2013.08.003.","journal-title":"J Vasc Surg"},{"issue":"25","key":"4589_CR21","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","volume":"28","author":"PC Austin","year":"2009","unstructured":"Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083\u2013107. https:\/\/doi.org\/10.1002\/sim.3697.","journal-title":"Stat Med"},{"issue":"12","key":"4589_CR22","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1007\/s00380-021-01871-6","volume":"36","author":"S Shirai","year":"2021","unstructured":"Shirai S, Hirano K, Mori S, Makino K, Honda Y, Tsutsumi M, et al. Frequency, predictors, and effect of the slow-flow phenomenon after drug-coated balloon angioplasty for femoropopliteal lesions. Heart Vessels. 2021;36(12):1818\u201324. https:\/\/doi.org\/10.1007\/s00380-021-01871-6.","journal-title":"Heart Vessels"},{"issue":"1","key":"4589_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ihj.2023.01.005","volume":"75","author":"Y Arita","year":"2023","unstructured":"Arita Y, Fukui T, Ogasawara N. Slow-flow phenomenon after drug-coated balloon angioplasty for lower-extremity arteries is associated with lack of prescribing of calcium channel blockers. Indian Heart J. 2023;75(1):82\u20135. https:\/\/doi.org\/10.1016\/j.ihj.2023.01.005.","journal-title":"Indian Heart J"},{"issue":"3","key":"4589_CR24","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s12928-021-00815-1","volume":"37","author":"K Fukai","year":"2022","unstructured":"Fukai K, Nakagami T, Hamaoka T, Kikai M, Yamaguchi S. Clinical outcome of the patients with femoropopliteal artery disease after endovascular therapy: focused on drug-coated-balloon-related distal embolism detected by laser doppler flowmetry. Cardiovasc Interv Ther. 2022;37(3):526\u201332. https:\/\/doi.org\/10.1007\/s12928-021-00815-1.","journal-title":"Cardiovasc Interv Ther"},{"key":"4589_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jvir.2018.07.025","volume":"30","author":"S Torii","year":"2019","unstructured":"Torii S, Jinnouchi H, Sakamoto A, et al. Comparison of biologic effect and particulate embolization after femoral artery treatment with three drug-coated balloons in healthy swine model. J Vasc Interv Radiol. 2019;30:103\u20139. https:\/\/doi.org\/10.1016\/j.jvir.2018.07.025.","journal-title":"J Vasc Interv Radiol"},{"issue":"6","key":"4589_CR26","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1177\/15266028231161215","volume":"31","author":"M Yoshikawa","year":"2024","unstructured":"Yoshikawa M, Torii S, Aihara K, Ito M, Nakamura N, Noda S, et al. Differences in biologic drug effects and distal particulate embolization in three paclitaxel-coated balloons for femoropopliteal lesions in a rabbit model. J Endovasc Ther. 2024;31(6):1234\u201343. https:\/\/doi.org\/10.1177\/15266028231161215.","journal-title":"J Endovasc Ther"},{"issue":"5","key":"4589_CR27","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1177\/15266028211025023","volume":"28","author":"Y Hata","year":"2021","unstructured":"Hata Y, Iida O, Ito N, Soga Y, Fukunaga M, Kawasaki D, et al. Roles of angioplasty with drug-coated balloon for chronic ischemia in wound healing. J Endovasc Ther. 2021;28(5):778\u201387. https:\/\/doi.org\/10.1177\/15266028211025023.","journal-title":"J Endovasc Ther"},{"issue":"3","key":"4589_CR28","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1002\/ccd.70033","volume":"106","author":"H Yamane","year":"2025","unstructured":"Yamane H, Hata Y, Iida O, Ueda Y, Ikeoka K, Toyoshima T, et al. Impact of femoropopliteal drug-coated balloon use on clinical outcomes in patients with chronic limb-threatening ischemia. Catheter Cardiovasc Interv. 2025;106(3):1993\u20132004. https:\/\/doi.org\/10.1002\/ccd.70033.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"10508","key":"4589_CR29","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/S0140-6736(25)01585-5","volume":"406","author":"M Falkenberg","year":"2025","unstructured":"Falkenberg M, James S, Andersson M, Andersson M, Delle M, Engstr\u00f6m J, et al. Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in chronic limb-threatening ischaemia (SWEDEPAD 1): a multicentre, participant-masked, registry-based, randomised controlled trial. Lancet. 2025;406(10508):1103\u201314. https:\/\/doi.org\/10.1016\/S0140-6736(25)01585-5.","journal-title":"Lancet"},{"issue":"14","key":"4589_CR30","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/j.jcin.2022.05.030","volume":"15","author":"R Nakamura","year":"2022","unstructured":"Nakamura R, Torii S, Kato T, et al. A case of vasculitis due to distal particulate embolization after use of drug-coated balloon. JACC Cardiovasc Interv. 2022;15(14):1486\u20137. https:\/\/doi.org\/10.1016\/j.jcin.2022.05.030.","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"4589_CR31","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ejvs.2021.05.027","volume":"63","author":"K Katsanos","year":"2022","unstructured":"Katsanos K, Spiliopoulos S, Teichgr\u00e4ber U, Kitrou P, Del Giudice C, Bj\u00f6rkman P, et al. Editor\u2019s choice - risk of major amputation following application of paclitaxel coated balloons in the lower limb arteries: a systematic review and meta-analysis of randomised controlled trials. Eur J Vasc Endovasc Surg. 2022;63(1):60\u201371. https:\/\/doi.org\/10.1016\/j.ejvs.2021.05.027.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"2","key":"4589_CR32","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jvir.2019.11.015","volume":"31","author":"K Katsanos","year":"2020","unstructured":"Katsanos K, Spiliopoulos S, Kitrou P, Krokidis M, Paraskevopoulos I, Karnabatidis D. Risk of death and amputation with use of paclitaxel-coated balloons in the infrapopliteal arteries for treatment of critical limb ischemia: a systematic review and meta-analysis of randomized controlled trials. J Vasc Interv Radiol. 2020;31(2):202\u201312. https:\/\/doi.org\/10.1016\/j.jvir.2019.11.015.","journal-title":"J Vasc Interv Radiol"},{"issue":"3","key":"4589_CR33","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.jvs.2021.01.041","volume":"74","author":"Y Xu","year":"2021","unstructured":"Xu Y, Liu J, Zhang J, Zhuang B, Jia X, Fu W, et al. Long-term safety and efficacy of angioplasty of femoropopliteal artery disease with drug-coated balloons from the AcoArt I trial. J Vasc Surg. 2021;74(3):756\u201362. https:\/\/doi.org\/10.1016\/j.jvs.2021.01.041.","journal-title":"J Vasc Surg"},{"issue":"10","key":"4589_CR34","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s00270-023-03478-y","volume":"46","author":"MMPJ Reijnen","year":"2023","unstructured":"Reijnen MMPJ, van Wijck I, Brodmann M, Micari A, Torsello G, Rha SW, et al. Five-year outcomes after paclitaxel drug-coated balloon treatment of femoropopliteal lesions in diabetic and chronic limb-threatening ischemia cohorts: IN.PACT global study post hoc analysis. Cardiovasc Intervent Radiol. 2023;46(10):1329\u201345. https:\/\/doi.org\/10.1007\/s00270-023-03478-y.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"4","key":"4589_CR35","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1177\/15266028231214167","volume":"32","author":"Y Tomoi","year":"2025","unstructured":"Tomoi Y, Takahara M, Soga Y, Hirano T, Tsunoda K, Katsuki T, et al. Effect of high-dose drug-coated balloon repetition after drug-coated balloon failure. J Endovasc Ther. 2025;32(4):1102\u20138. https:\/\/doi.org\/10.1177\/15266028231214167.","journal-title":"J Endovasc Ther"},{"issue":"6","key":"4589_CR36","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/ccd.31245","volume":"104","author":"T Yanagiuchi","year":"2024","unstructured":"Yanagiuchi T, Fukai K, Sogabe K, Iwasaki Y, Hirano K, Kato T, et al. Predictors of recurrent restenosis after repeat drug-coated balloon therapy for drug-coated balloon restenosis in femoropopliteal lesions: results of the RECURRENCE study. Catheter Cardiovasc Interv. 2024;104(6):1241\u201350. https:\/\/doi.org\/10.1002\/ccd.31245.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"3","key":"4589_CR37","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00380-024-02462-x","volume":"40","author":"Y Kozai","year":"2025","unstructured":"Kozai Y, Mori S, Mizusawa M, Shirai S, Honda Y, Tsutsumi M, et al. Efficacy of a novel method: vasodilator injection via the over-the-wire lumen during drug-coated balloon dilatation to prevent the slow-flow phenomenon in treatment of femoropopliteal lesions. Heart Vessels. 2025;40(3):251\u20137. https:\/\/doi.org\/10.1007\/s00380-024-02462-x.","journal-title":"Heart Vessels"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-026-04589-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-026-04589-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-026-04589-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:15:46Z","timestamp":1787775346000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-026-04589-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":37,"alternative-id":["4589"],"URL":"https:\/\/doi.org\/10.1007\/s00270-026-04589-y","relation":{},"ISSN":["1432-086X"],"issn-type":[{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"assertion":[{"value":"6 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received approval from the institutional review board at each participating center and adhered to the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Individual informed consent was waived, with an opt-out approach implemented for the use and disclosure of patient data.","order":3,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent for publication was obtained for every individual person\u2019s data included in the study.","order":4,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}